Chengdu Kangnuoxing Biopharma,inc.

This study is testing the safety of a new biologic drug called stapokibart in 600 adults with chronic sinusitis and nasal polyps (CRSwNP). Participants receive the drug as a shot under the skin. The main goal is to track any side effects or serious health events. This is an open-…